Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140018/S050

VenaSeal Closure System

Medtronic Vascular, Inc. · Decision date Oct 15, 2026

MEDTECHLEDGER EXPLANATIONP140018/S050

What did the FDA decide?

The FDA recorded a 30-Day Notice decision dated 2026-10-15 for P140018/S050, a supplement to the VenaSeal™ Closure System held by Medtronic Vascular, Inc. The listed device category is an occluding vascular agent intended to be permanent, with product code PJQ under the Cardiovascular specialty. The recorded statement covers approval for design, material, and manufacturing changes to components of the dispenser gun.

This action concerns the dispenser gun components rather than a new approval of the whole system, and the source does not identify which components changed, the nature of the design or material changes, or any supporting documents. The supplement reason is listed as a process change involving manufacturer, sterilizer, packager, or supplier. No clinical, performance, or labeling information accompanies the record, so the practical effect of the change cannot be assessed from this data alone.

FDA approval order statement

approval for design, material, and manufacturing changes to components of the dispenser gun
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 15, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P140018/S050
Regulatory pathway
PMA supplement
Product code
PJQ
Decision code
OK30
Decision date
Oct 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Agent, occluding, vascular, permanent.

Product code
PJQ
FDA device class
3

For the original device and its historical approval scope, see PMA P140018. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P140018 · Original PMA

    VENASEAL CLOSURE SYSTEM

  2. P140018/S050 received

    Application receipt date recorded by FDA.

  3. P140018/S050 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P140018. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140018

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Vascular, Inc.PMA approvalFeb 20, 2015FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Vascular, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3033 Campus Dr., Plymouth, MN, 55441

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records